Stronger and sustained Th1 (Day 5) and Th2/Tfh responses in adults; higher IL‐4 and antibody (IgG, IgG1, IgG2a, MSP‐1–specific) levels; lower PD‐1 expression and reduced parasitemia; higher survival (96%). The gene discussed is ATAD1; the disease is parasitic infectious disease.